Owen Hughes
Chief Executive Officer bij XOMA CORPORATION
Vermogen: 135 075 $ op 31-03-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Anthony Adam Rosenberg | M | 71 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 9 jaar |
George Martin | M | 65 |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | 9 jaar |
Nadim Ahmed | M | 56 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 3 jaar |
William Irving | M | - |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. They also sub-advice funds or accounts for affiliated advisers and unaffiliated advisers. | 18 jaar |
Jean-Francois Formela | M | 67 | 13 jaar | |
Mark Manfredi | M | 53 | 8 jaar | |
Kendra Adams | F | 48 | 4 jaar | |
Stephen Webster | M | 63 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 4 jaar |
Michael Jarasitis | M | - |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. They also sub-advice funds or accounts for affiliated advisers and unaffiliated advisers. | 18 jaar |
Steven Helwig | M | 51 | 9 jaar | |
Thomas Ebeling | M | 65 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 7 jaar |
Kenneth Anderson | M | 72 | 9 jaar | |
Bihua Chen | F | 55 | 9 jaar | |
Jennifer Michaelson | M | 57 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 6 jaar |
Jack Wyszomierski | M | 68 | 14 jaar | |
Bruce Downey | M | 76 | 9 jaar | |
Richard Wooster | M | 59 | 5 jaar | |
Andrew Hirsch | M | 53 | 4 jaar | |
Andrew von Eschenbach | M | 82 |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | 5 jaar |
William Daniel | M | 72 | 9 jaar | |
Samuel Cohen | M | 38 |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | 8 jaar |
Jolie Siegel | F | 47 | 4 jaar | |
Chhaya Shah | F | 60 | 6 jaar | |
Christopher Dobson | M | 75 |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | 8 jaar |
Michele Vendruscolo | F | 58 |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | 8 jaar |
Malcolm Salter | M | 84 | 9 jaar | |
Laura Bessen | M | 61 | 2 jaar | |
Utpal Koppikar | M | 53 | 2 jaar | |
Corinne Savill | M | 64 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 7 jaar |
Jeffrey Ecsedy | M | 54 | 7 jaar | |
Maria Koehler | M | 67 | 3 jaar | |
Bruce Mitlak | M | - | 8 jaar | |
Heather Franklin | F | 58 | 3 jaar | |
Thomas Burns | M | 50 | 18 jaar | |
Mark Schmehl | M | - |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. They also sub-advice funds or accounts for affiliated advisers and unaffiliated advisers. | 17 jaar |
Glenn Dubin | M | 67 | 3 jaar | |
Dan Tremblay | M | - |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. They also sub-advice funds or accounts for affiliated advisers and unaffiliated advisers. | 18 jaar |
Charles Ackerman | M | - |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. They also sub-advice funds or accounts for affiliated advisers and unaffiliated advisers. | 18 jaar |
David Bonita | M | 48 | - | |
Otello Stampacchia | M | 55 | 4 jaar | |
Jean-Michel Cossery | M | 65 | 6 jaar | |
Matthew Perry | M | 51 | 7 jaar | |
Barbara Kosacz | F | 66 | 5 jaar | |
Joseph Limber | M | 71 | 12 jaar | |
Donna Grogan | M | 67 | 2 jaar | |
Iain Dukes | M | 65 | 8 jaar | |
Peter A. Schwartzman | M | - | 4 jaar | |
Rudy Mareel | M | 61 | 6 jaar | |
Natasha Hernday | F | 52 | 4 jaar | |
Joan Gray | F | - | 3 jaar | |
Stephanie Torruella | F | - | 4 jaar | |
Rohan Lathia | M | - | 3 jaar | |
Michelle Zhang | M | - | 8 jaar | |
Travis Wilson | M | - | 2 jaar | |
Salvador Grausso | M | 49 | 4 jaar | |
Laura Furmanski | F | - | 2 jaar | |
Cole Ikkala | M | - | 4 jaar | |
Rupert Haynes | M | - | 3 jaar | |
Jotin Marango | M | 45 | 2 jaar | |
Ethan Hugo | M | - |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. They also sub-advice funds or accounts for affiliated advisers and unaffiliated advisers. | 18 jaar |
Mark Mossler | M | 51 | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Ronald Renaud | M | 55 | 8 jaar | |
Raymond T. Keane | M | 65 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | 9 jaar |
Patrick Baeuerle | M | 66 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 7 jaar |
Ansbert Gadicke | M | 66 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 11 jaar |
Young Duchung Chin | M | - |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. They also sub-advice funds or accounts for affiliated advisers and unaffiliated advisers. | 7 jaar |
Daniel Dolan | M | 47 | 4 jaar | |
Adrian Howd | M | 52 | 3 jaar | |
James Chopas | M | 58 | 3 jaar | |
Jesper Høiland | M | 63 | 3 jaar | |
Jon Wigginton | M | 62 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 2 jaar |
Darragh Lyons | M | 43 | 8 jaar | |
Jose Carmona | M | 51 | 3 jaar | |
Michael Wyzga | M | 69 | 2 jaar | |
Mark Conley | M | 62 | 2 jaar | |
Donal O'Connor | M | 73 | 1 jaar | |
Michael Heartlein | M | 65 | 9 jaar | |
John R. Schroer | M | 58 | 2 jaar | |
Anderson Timothy | M | - |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 2 jaar |
Averi Price | F | - | 6 jaar | |
Paul Burgess | M | 50 | 6 jaar | |
Jeffrey Trigilio | M | 40 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 4 jaar |
Morana Jovan-Embiricos | M | 57 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 7 jaar |
Andrew Fromkin | M | 58 | - | |
W. van Ness | M | 81 | 42 jaar | |
Brian Harvey | M | 63 | 11 jaar | |
Robert E. Ward | M | 66 | 4 jaar | |
Brent Hatzis-Schoch | M | 59 | 4 jaar | |
Erick Lucera | M | 57 |
Triathlon Fund Management LLC
Triathlon Fund Management LLC Investment ManagersFinance Triathlon Fund Management LLC is a hedge fund headquartered in Boston. | 3 jaar |
Kyran McLaughlin | M | 80 | 2 jaar | |
Martin C. Münchbach | M | 54 | 4 jaar | |
Robert Alexander Ingram | M | 81 | 3 jaar | |
Jonathan Fleming | M | 66 | 2 jaar | |
Sean Murphy | M | 71 | 2 jaar | |
Elhan Webb | F | - | - | |
Gary Hattersley | M | 57 | 15 jaar | |
Alan Auerbach | M | 54 | 6 jaar | |
Kurt Graves | M | 56 | 9 jaar | |
Catherine Friedman | F | 63 | 7 jaar | |
Elizabeth Stoner | M | 73 | 4 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 89 | 89.00% |
Ierland | 9 | 9.00% |
Verenigd Koninkrijk | 5 | 5.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Owen Hughes
- Persoonlijk netwerk